Shanghai No.1 PharmacyLtd Valuation
Is 600833 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 600833 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 600833 (CN¥11.19) is trading above our estimate of fair value (CN¥2.78)
Significantly Below Fair Value: 600833 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 600833?
Other financial metrics that can be useful for relative valuation.
| What is 600833's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥2.50b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | 129.4x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 600833's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 33.4x | ||
300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | 56.5x | n/a | CN¥2.1b |
301408 Anhui Huaren Health Pharmaceutical | 25x | n/a | CN¥4.5b |
301017 ShuYu Civilian Pharmacy | 38.3x | n/a | CN¥5.1b |
605266 Jianzhijia Pharmaceutical Chain Group | 13.8x | 18.8% | CN¥6.1b |
600833 Shanghai No.1 PharmacyLtd | 28x | n/a | CN¥2.5b |
Price-To-Earnings vs Peers: 600833 is good value based on its Price-To-Earnings Ratio (28x) compared to the peer average (33.4x).
Price to Earnings Ratio vs Industry
How does 600833's PE Ratio compare vs other companies in the CN Consumer Retailing Industry?
Price-To-Earnings vs Industry: 600833 is expensive based on its Price-To-Earnings Ratio (28x) compared to the CN Consumer Retailing industry average (26.5x).
Price to Earnings Ratio vs Fair Ratio
What is 600833's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 28x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 600833's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.